Agreement with Mayo Clinic for EchoSolv HF

Summary by 6ix AI

EchoIQ Limited has announced an expanded agreement with Mayo Clinic for the distribution of its heart failure clinical decision support solution, EchoSolv HF, pending FDA clearance. The revised agreement includes improved commercial terms and an automatic extension for a potential six-year partnership. This collaboration aims to leverage Mayo Clinic's extensive healthcare network to facilitate broader adoption of EchoSolv HF across various hospitals.

Written by 6ix AI from the company’s filing. How 6ix writes summaries